Department of Internal Medicine/Institute of Gerontology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Aging Cell. 2009 Sep;8(5):542-52. doi: 10.1111/j.1474-9726.2009.00504.x. Epub 2009 Jul 9.
dTOR (target of rapamycin) and dFoxo respond to changes in the nutritional environment to induce a broad range of responses in multiple tissue types. Both dTOR and dFoxo have been demonstrated to control the rate of age-related decline in cardiac function. Here, we show that the Eif4e-binding protein (d4eBP) is sufficient to protect long-term cardiac function against age-related decline and that up-regulation of dEif4e is sufficient to recapitulate the effects of high dTOR or insulin signaling. We also provide evidence that d4eBP acts tissue-autonomously and downstream of dTOR and dFoxo in the myocardium, where it enhances cardiac stress resistance and maintains normal heart rate and myogenic rhythm. Another effector of dTOR and insulin signaling, dS6K, may influence cardiac aging nonautonomously through its activity in the insulin-producing cells, possibly by regulating dilp2 expression. Thus, elevating d4eBP activity in cardiac tissue represents an effective organ-specific means for slowing or reversing cardiac functional changes brought about by normal aging.
dTOR(雷帕霉素靶蛋白)和 dFoxo 响应营养环境的变化,在多种组织类型中诱导广泛的反应。dTOR 和 dFoxo 都被证明可以控制与年龄相关的心脏功能下降的速度。在这里,我们表明 Eif4e 结合蛋白(d4eBP)足以保护长期心脏功能免受与年龄相关的下降,而上调 dEif4e 足以再现高 dTOR 或胰岛素信号的作用。我们还提供了证据表明,d4eBP 在心肌中独立于组织发挥作用,并作为 dTOR 和 dFoxo 的下游,在心肌中增强心脏应激抗性并维持正常心率和肌源性节律。dTOR 和胰岛素信号的另一个效应物 dS6K,可能通过其在胰岛素产生细胞中的活性,通过调节 dilp2 的表达,非自主地影响心脏衰老。因此,提高心脏组织中的 d4eBP 活性是一种减缓或逆转正常衰老引起的心脏功能变化的有效器官特异性方法。